StockData
NeuroSense Therapeutics Ltd. logo

NeuroSense Therapeutics Ltd. (NRSN) stock

NRSNNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NRSNW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$1.37−0.14 (-9.27%)

Close on Nov 18, 2026Market cap $2.52MP/E –Yield –

NeuroSense Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

NeuroSense Therapeutics's market cap was $3.27M on Nov 11, 2026, against $29.28M a year earlier. Over the last 5 years it ranged from $58.04K to $43.90M, with a median of $17.70M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.27M-82.7%
2025Dec 31, 2025$18.92M-12.7%
2024Dec 31, 2024$21.67M+21804.8%
2023Dec 29, 2023$98.91K-98.7%
2022Dec 30, 2022$7.62M–

More NeuroSense Therapeutics figures

See a number that looks wrong?